A detailed history of Amalgamated Bank transactions in Wave Life Sciences Ltd. stock. As of the latest transaction made, Amalgamated Bank holds 2,500 shares of WVE stock, worth $35,650. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2,500
Previous 2,500 -0.0%
Holding current value
$35,650
Previous $12,000 75.0%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 23, 2024

SELL
$3.54 - $6.84 $9,409 - $18,180
-2,658 Reduced 51.53%
2,500 $15,000
Q4 2023

Feb 06, 2024

SELL
$4.16 - $6.87 $2,466 - $4,073
-593 Reduced 10.31%
5,158 $26,000
Q2 2023

Aug 11, 2023

BUY
$3.51 - $4.69 $20,186 - $26,972
5,751 New
5,751 $20,000
Q2 2022

Aug 15, 2022

SELL
$1.23 - $3.25 $8,878 - $23,458
-7,218 Closed
0 $0
Q1 2022

Jun 30, 2022

BUY
$2.0 - $3.28 $14,436 - $23,675
7,218 New
7,218 $14,000

Others Institutions Holding WVE

About Wave Life Sciences Ltd.


  • Ticker WVE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 86,820,096
  • Market Cap $1.24B
  • Description
  • Wave Life Sciences Ltd., a clinical stage genetic medicine company, designs, optimizes, and produces novel stereopure oligonucleotides through PRISM, a discovery and drug developing platform. It is developing oligonucleotides target ribonucleic acid to reduce the expression of disease-promoting proteins or restore the production of functional pr...
More about WVE
Track This Portfolio

Track Amalgamated Bank Portfolio

Follow Amalgamated Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Amalgamated Bank, based on Form 13F filings with the SEC.

News

Stay updated on Amalgamated Bank with notifications on news.